US pharmaceutical corporation Pfizer’s
COVID-19 vaccine deliveries to Norway and Europe are to be cut short “as of
next week” as the company notches up its production capacity, AFP reported.

“The temporary reduction will
affect all European countries,” Norway’s Public Health Agency (FHI) was
quoted as saying in a statement.

Also read: Israel completes two million COVID-19 vaccinations

The exact amount of time that Pfizer
will take in order to ramp up their production to the maximum capacity is not known
yet. The production, however, is reportedly expected to be rising from 1.3
billion to 2 billion annually.

While coming up with no figures regarding
Europe, FHI said that Norway would receive 36,075 doses next week – a drop from
the previous 48,875, a notable 17.8% drop.

Also read: Vaccination in Vatican begins, Pope Francis, former Pope Benedict receive jabs

To compensate, the Scandinavian
country would be using a portion of reserves it had set aside after receiving
its allotted share of vaccines.

Though not a member of the European
Union, the northern European nation is close-linked to the bloc in many areas, including
the procurement of vaccines.